Structured Abstract
Background and Objectives Disparate colorectal cancer outcomes persist in vulnerable populations. We aimed to examine the distribution of research across the colorectal cancer care continuum, and to determine disparities in the use of Surgery among Black patients.
Methods A systematic review and meta-analysis of colorectal cancer disparities studies was performed. The meta-analysis assessed three utilization measures in Surgery.
Results Of 1,199 publications, 60% focused on Prevention, Screening, or Diagnosis, 20% on Survivorship, 15% on Treatment, and 1% on End-of-Life Care. A total of 16 studies, including 1,110,674 patients, were applied to three separate meta-analyses regarding utilization of Surgery. Black colorectal cancer patients were less likely to receive surgery, twice as likely to refuse surgery, and less likely to receive laparoscopic surgery when compared to White patients.
Conclusions Over the past 10 years, the majority of published research remained focused on the prevention, screening, or diagnosis domain. Given the observed treatment disparities and persistently elevated disease-specific mortality among Black patients, future efforts to reduce colorectal cancer disparities should include interventions within Surgery.
Synopsis In this systematic review on disparities along the colorectal cancer care continuum, we found that 64% of research has been focused on prevention, screening, or diagnosis while only 6% addressed surgical disparities. In the meta-analysis, Black patients were less likely to undergo surgery, more likely to refuse surgery, and less likely to undergo laparoscopic surgery, when compared to White patients. Future research should target treatment differences across populations in order to impact persistent disparities in colorectal cancer survival.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Exempt from IRB review
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Disclosures and Funding Sources: Nothing to disclose.
Data Availability
Online publications Citations 11-24
